Skip to content

Prostate Cancer Multigene Analysis (Blood)

Published: August 9, 2026Updated: August 17, 2026

This blood test analyzes multiple genes linked to prostate cancer risk or progression. It may help assess whether your prostate cancer has specific genetic features that could influence treatment options or outcomes.

Quick summary

["This test provides personalized insights into your prostate cancer based on genetic markers found in your blood."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
100213-8
Short code
Prostate cancer multigene analysis Bld/T
Synonyms
Prostate cancer multigene analysis Bld/T
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Critical range
0.5 N/A – —
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
CPT
86038
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The test evaluates multiple genes associated with prostate cancer, including those involved in tumor growth, response to treatment, or recurrence risk. Specific genes may be analyzed through advanced molecular techniques to identify patterns that could affect your care plan.

Why Might You Need This Test?

Your healthcare provider may recommend this test if you have prostate cancer, are at high risk for it, or if your cancer has certain genetic traits that could guide treatment decisions. It may also be used in research or clinical trials to better understand prostate cancer biology.

How Is the Test Performed?

A small blood sample is drawn from your arm. The sample is then processed in a laboratory to extract DNA, which is analyzed for specific genetic markers. This process typically takes several days to complete, depending on laboratory workflows.

What Are the Possible Outcomes?

Results may identify genetic variations that could influence your cancer’s behavior, such as how it grows, responds to therapies, or risks returning. Some findings may help determine whether you’re a candidate for targeted treatments or clinical trials.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Multigene Prostate Cancer Test

Frequently asked questions

Will this test change my treatment plan immediately?
Possibly. Based on the genetic findings, your doctor may recommend adjustments to your treatment, such as different medications, therapies, or monitoring strategies. However, results take time to analyze, so discuss findings with your healthcare team before making decisions.
How long will I need to wait for results?
Results typically take 2 to 6 weeks or longer, depending on laboratory processing and follow-up steps. Your provider will coordinate with the lab to ensure you receive timely updates.
Is this test covered by insurance?
Coverage depends on your insurance plan, medical necessity, and whether your doctor orders it as part of your standard care. Check with your insurance provider or healthcare team to confirm coverage details before the test.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy